70 related articles for article (PubMed ID: 19877750)
1. A case-control study on risk factors of osteoporosisin patients with Crohn's disease.
Vahedi H; Momtahen S; Olfati G; Abtahi A; Hosseini S; Kazzazi AS; Khademi H; Rashtak S; Khaleghnejad R; Tabrizian T; Hamidi Z; Nouraie M; Malekzadeh F; Merat S; Nasseri-Moghaddam S; Sotoudehmanesh R; Larijani B
Arch Iran Med; 2009 Nov; 12(6):570-5. PubMed ID: 19877750
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
de Jong DJ; Corstens FH; Mannaerts L; van Rossum LG; Naber AH
Am J Gastroenterol; 2002 Aug; 97(8):2011-5. PubMed ID: 12190169
[TBL] [Abstract][Full Text] [Related]
3. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
4. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn's disease.
Roblin X; Phelip JM; Genevois M; Ducros V; Bonaz B
Aliment Pharmacol Ther; 2007 Apr; 25(7):797-804. PubMed ID: 17373918
[TBL] [Abstract][Full Text] [Related]
6. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.
Lee N; Fowler E; Mason S; Lincoln D; Taaffe DR; Radford-Smith G
J Gastroenterol Hepatol; 2007 Jun; 22(6):913-9. PubMed ID: 17565648
[TBL] [Abstract][Full Text] [Related]
8. Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis.
Dear KL; Compston JE; Hunter JO
Clin Nutr; 2001 Dec; 20(6):541-6. PubMed ID: 11884003
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
Vestergaard P
Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
[TBL] [Abstract][Full Text] [Related]
10. [Low bone mineral density in children with Crohn's disease].
Bourges O; Dorgeret S; Alberti C; Hugot JP; Sebag G; Cézard JP
Arch Pediatr; 2004 Jul; 11(7):800-6. PubMed ID: 15234375
[TBL] [Abstract][Full Text] [Related]
11. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
[TBL] [Abstract][Full Text] [Related]
12. Negative impact of Crohn's disease on bone mineral mass.
Thodis E; Rossos P; Habal F; Oreopoulos D
J Musculoskelet Neuronal Interact; 2003 Sep; 3(3):246-50. PubMed ID: 15758348
[TBL] [Abstract][Full Text] [Related]
13. Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients.
Andreassen H; Hylander E; Rix M
Am J Gastroenterol; 1999 Mar; 94(3):824-8. PubMed ID: 10086673
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
15. Review article: Osteoporosis and inflammatory bowel disease.
Bernstein CN; Leslie WD
Aliment Pharmacol Ther; 2004 May; 19(9):941-52. PubMed ID: 15113361
[TBL] [Abstract][Full Text] [Related]
16. Osteopenia in Puerto Ricans with Crohn's disease.
Chinea B; Rosa A; Oharriz JJ; Ramírez M; Haddock L; Pérez C; Torres EA
P R Health Sci J; 2000 Dec; 19(4):329-33. PubMed ID: 11293884
[TBL] [Abstract][Full Text] [Related]
17. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
[TBL] [Abstract][Full Text] [Related]
19. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Aug; 98(8):1797-801. PubMed ID: 12907335
[TBL] [Abstract][Full Text] [Related]
20. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
